09939.HK

Aug 20, 2026, 01:48 UTC

Kintor Pharmaceutical reported interim results for the six months ended June 2026, with revenue of RMB 52.04 million, up about 7.7 times year-on-year, and a narrowed net loss of RMB 75.782 million from RMB 83.268 million a year earlier.